Navigation Links
Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedix's $20.7 Million Equity Financing
Date:11/17/2009

SAN FRANCISCO, Nov. 17 /PRNewswire-FirstCall/ -- Merriman Curhan Ford Group, Inc. (Nasdaq: MERR) acted as lead placement agent in PolyMedix Inc.'s (OTC Bulletin Board: PYMX) $20.7 million registered public offering of 20.7 million units. The units, which were priced at $1.00 per unit, consist of one share of PolyMedix common stock and one five year warrant to purchase 0.30 of a share of PolyMedix common stock at $1.25 per share.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090911/MCFLOGO)

The company announced the pricing of the public offering on November 11, 2009 and the closing on November 16, 2009. Details on the transaction can be found at PolyMedix's Web site: www.polymedix.com.

About PolyMedix, Inc.

PolyMedix is a publicly traded biotechnology company focused on the development of novel drugs and biomaterials for the treatment of infectious diseases and acute cardiovascular disorders. PolyMedix's compounds are based on biomimetics: non-peptide small molecule drugs that mimic the activity of proteins. The Company's antibiotic compound's small molecule mimetics of human host-defense proteins are believed to have a completely different mechanism of action from all current antibiotic drugs, a mechanism which is intended to make bacterial resistance unlikely to develop. These compounds are being developed as broadspectrum, rapid-acting antibiotics for serious systemic and local infections. The Company is also developing polymeric formulations as antimicrobial biomaterials, which can be used as additives to paints, plastics, and textiles to create self-sterilizing products and surfaces. T
'/>"/>

SOURCE Merriman Curhan Ford
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SuperGen to Present at Merriman 5th Annual Investor Summit on September 15, 2008
2. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
3. ProMetic to present at Merriman Curhan Fords Investor Summit 2008 on September 16th
4. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
5. Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th
6. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
7. Pharmaxis Announces Placement of $50 Million and Share Purchase Plan
8. XTL Biopharmaceuticals Ltd. Announces $9.6 Million Private Placement to Institutional Investors
9. Helix BioPharma announces $16.9 million private placement of common shares
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Ardea Biosciences Announces $40 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Cellular Biomedicine ... achieved 50% enrollment of the total projected enrollment ... the safety and preliminary efficacy of the medical ... for Knee Osteoarthritis (KOA). To date the trial ... The Phase I open label clinical ...
(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce ... Switzerland -based Kenta Biotech to acquire ... (mAb) products, and technologies. This asset portfolio purchase ... of infections by common pathogens including drug resistant ... Pseudomonas aeruginosa , Acinetobacter baumannii and ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Men’s skin is ... La-roche Posay ) and has been known to react ... some men may be far from puberty, other acne causing ... pores, causing breakouts, and threatening skin with unsightly acne scars. ... from Men’s Health on how to reduce and ...
(Date:5/17/2013)... May 17, 2013 RURO Inc. ... version 4.1, a versatile refinement to the smart ... solution, improves its advanced methodical management for transgenic ... ezColony 4.1. The network-based platform provides user access ... research. While continuing to emphasize streamlined tasks, such ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2
... a "biotech hotspot," this time in e-mail newsletter FierceBiotech. ... profile and is just what the biotech industry has ... of five hotspots were California, Maryland, New Jersey and ... list, told Forbes it was a subjective ranking based ...
... qualified for investor tax credits under Wisconsin's Act 255. That ... companies so far have come from. Wisconsin gives the tax ... , StrandVision , in Eau Claire, makes digital signs ... Systems & Services Inc. , in Sheboygan, provides engineering, production ...
... has posted a $21 million bond to pay damages and ... in a patent case, pending appeal. , ,Third Wave and ... has the right to commercialize certain molecular diagnostics methods. A ... later awarded them tripled damages of $15.9 million. , ,Stratagene ...
Cached Biology Technology:
(Date:5/17/2013)... the science and technology of the region and ... inaugural Atlanta Science Festival, March 22-29, 2014. With ... K-12 schools and universities, the festival will host ... adults at venues across the city. Learn more ... Atlanta Science Festival is a collaboration of scientific, ...
(Date:5/17/2013)... Dartmouth College study finds human-caused climate change may ... lizards, contradicting a host of recent studies that ... planet. , The findings, which appear in the ... hope for survival of a creature thought to ... that tropical cold-blooded animals, especially forest lizards, will ...
(Date:5/16/2013)... MD FASEB MARC (Maximizing Access to Research ... for The Endocrine Society (ENDO) 95th Annual Meeting ... These awards are meant to promote the entry ... into the mainstream of the basic science community ... at the ENDO 2013 Annual Meeting. , Awards ...
Breaking Biology News(10 mins):First Atlanta Science Festival set for 2014 2Climate change may have little impact on tropical lizards 2
... This release is available in Spanish . ... , Spain, have generated artificial human skin by tissular engineering ... mice, and optimal development, maturation and functionality results were obtained. ... skin and its use in many laboratory tests on biological ...
... Duke University Medical Center and Laboratory Corporation of ... formation of a joint venture to commercialize new ... the translation of newly discovered biomarkers into widely ... responses, predict disease progression, and evaluate any number ...
... CA April 19, 2010 Scientists from The Scripps ... of how certain genetic mutations lead to Type 1 diabetes. ... Type 1 diabetes and other autoimmune diseases. The study ... Journal of Clinical Investigation on April 19, 2010, and ...
Cached Biology News:Scientists create artificial human skin with biomechanical properties using tissue engineering 2Duke, LabCorp combine forces to create the Biomarker Factory 2Scripps Research scientists reveal how genetic mutations may cause type 1 diabetes 2Scripps Research scientists reveal how genetic mutations may cause type 1 diabetes 3
Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Human peripheral blood basophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
... an anodized aluminum, solvent-resistant block specially designed ... efficient thermal transfer to samples within the ... HT96 Isothermal Block replaces Cat. No. 71031-3, ... for compatibility with robotic applications. The new ...
Biology Products: